checkAd
    Startseite > Aktien > X4 Pharmaceuticals > Nachrichten
    X4 Pharmaceuticals Aktie
    0,9710
     
    EUR
    +4,35 %
    +0,0405 EUR
    Letzter Kurs 10.06.24 Tradegate
    0,9410
     
    EUR
    1.600 STK
    Geldkurs 13:18:29
    0,9890
     
    EUR
    1.600 STK
    Briefkurs 13:18:29
    ISIN: US98420X1037 · WKN: A2PFVY · SYM: 48Q · USA

    Neueste Nachrichten

    X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    03.06.24 · globenewswire · X4 Pharmaceuticals
    X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia
    29.05.24 · globenewswire · X4 Pharmaceuticals
    X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
    13.05.24 · globenewswire · X4 Pharmaceuticals
    X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
    09.05.24 · globenewswire · X4 Pharmaceuticals
    X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
    07.05.24 · globenewswire · X4 Pharmaceuticals
    X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    01.05.24 · globenewswire · X4 Pharmaceuticals
    X4 Pharmaceuticals to Report First-Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 7, 2024
    30.04.24 · globenewswire · X4 Pharmaceuticals
    X4 Pharmaceuticals Announces FDA Approval of XOLREMDI (mavorixafor) Capsules, First Drug Indicated in Patients with WHIM Syndrome
    29.04.24 · globenewswire · X4 Pharmaceuticals
    X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    02.04.24 · globenewswire · X4 Pharmaceuticals
    X4 Pharmaceuticals to Participate in Upcoming April Investor Conferences
    01.04.24 · globenewswire · X4 Pharmaceuticals
    X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
    21.03.24 · globenewswire · X4 Pharmaceuticals
    X4 Pharmaceuticals to Report Fourth-Quarter and Full Year 2023 Financial Results and Host a Conference Call and Webcast on March 21, 2024
    12.03.24 · globenewswire · X4 Pharmaceuticals